Clinical Perspectives

Beyond the CBC: Early Clues That Point to Hematologic Disease

Spot subtle blood cancer clues before symptoms appear.

Why Sarcoma Care Requires a Dedicated Team of Specialists

The nuances of sarcoma care start at diagnosis and continue through every treatment decision.

First Immunotherapy FDA Approval in Ovarian Cancer

In February 2026, the FDA approved the first immunotherapy for ovarian cancer, providing new options for patients with platinum-resistant recurrent...

Managing Common Non-Malignant Hematologic Disorders at Moffitt

Beyond Moffitt's expertise in malignant hematology, we also partner with community healthcare providers to treat complex, non-cancerous blood...

Now Open: Moffitt at Speros Outpatient Center in Pasco County

Moffitt at Speros represents the beginning of a significant expansion of access to NCI-designated Comprehensive Cancer Center care for patients in...

Merlin Test Refines Melanoma SLNB Selection

The gene expression test accurately identifies low-risk patients who can avoid sentinel node biopsy.

The 2-3 Week Rule: When “Persistent” Symptoms Deserve a Cancer Evaluation

Learn how to spot subtle signs of head and neck cancers to refer patients to Moffitt and save lives.

Direct Access to our Transplant and Cellular Immunotherapy Experts

When patients face challenging malignant or non-malignant hematologic diseases, timely referral to specialized care can make all the difference in...

The Critical Role of Surgeon Selection in Cancer Outcomes

Moffitt Cancer Center performs 850-900 cancer surgeries monthly. This case volume supports genuine subspecialization, where surgeons focus...

Expanding Access: Cellular Therapies and Autologous Stem Cell Transplants for Treatment-Resistant Autoimmune Disease

Moffitt has launched a new service specifically for non-cancer patients with autoimmune diseases like MS and SSc or Scleroderma who have relapsed...

New Treatments for Breast Cancer Leptomeningeal Disease Using the Patients' Own Immune Cells

LMD often emerges paradoxically when the systemic disease appears well-controlled, it creates a devastating disconnect between overall cancer...

Personalized Breast Cancer Immunotherapy Trials

In the evolving landscape of breast cancer treatment, two groundbreaking clinical trials at Moffitt are offering new hope to patients with aggressive...

Expanding Treatment Horizons: Moffitt's Approach to Stage IV Esophageal Cancer Surgery

Historically, surgery has been considered inappropriate for patients with stage IV esophageal cancer, but Moffitt's experts suggested that...

Improving Survival Rates in Esophageal Cancer: Why Early Referral Matters

Early referral to Moffitt provides esophageal cancer patients access to world-class GI cancer expertise.

Expanding Minimally Invasive Options for Lung Metastases: The Role of Thermal Ablation

Moffitt Cancer Center has been working to expand access to thermal ablation for appropriate patients in the Southeast.